About: Ambit Biosciences

An Entity of Type: company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.

Property	Value
dbo:abstract	Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. (en)
dbo:wikiPageID	42413595 (xsd:integer)
dbo:wikiPageLength	4518 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1024451595 (xsd:integer)
dbo:wikiPageWikiLink	dbr:San_Diego dbr:Product_lifecycle dbr:Pharmaceutical_industry dbc:Companies_based_in_San_Diego dbr:Daiichi_Sankyo dbc:Daiichi_Sankyo dbr:Foresite_Capital dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Health_care_companies_based_in_California dbc:Pharmaceutical_companies_of_the_United_States dbr:Growthworks dbr:Initial_public_offering dbr:Nasdaq dbr:Quizartinib dbr:OrbiMed_Advisors dbr:Kinase_inhibitor
dbp:date	June 2020 (en)
dbp:wikiPageUsesTemplate	dbt:As_of dbt:Clarification_needed dbt:Reflist dbt:Rp dbt:Med-company-stub
dcterms:subject	dbc:Companies_based_in_San_Diego dbc:Daiichi_Sankyo dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Health_care_companies_based_in_California dbc:Pharmaceutical_companies_of_the_United_States
gold:hypernym	dbr:Company
rdf:type	dbo:Company yago:WikicatCompaniesBasedInSanDiego,California yago:WikicatCompaniesListedOnNASDAQ yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates
rdfs:comment	Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. (en)
rdfs:label	Ambit Biosciences (en)
owl:sameAs	freebase:Ambit Biosciences yago-res:Ambit Biosciences wikidata:Ambit Biosciences https://global.dbpedia.org/id/eV75
prov:wasDerivedFrom	wikipedia-en:Ambit_Biosciences?oldid=1024451595&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Ambit_Biosciences
is dbo:wikiPageWikiLink of	dbr:Daiichi_Sankyo dbr:OrbiMed dbr:Quizartinib
is foaf:primaryTopic of	wikipedia-en:Ambit_Biosciences